<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Stock Value</title>
	<atom:link href="http://stock-value.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://stock-value.com</link>
	<description>Stock Market Value Investing Tips Techniques Theory and Tools</description>
	<pubDate>Tue, 23 Dec 2008 11:28:19 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
	<language>en</language>
			<item>
		<title>SSRX - S3Bio Inc</title>
		<link>http://stock-value.com/ssrx-s3bio-inc/</link>
		<comments>http://stock-value.com/ssrx-s3bio-inc/#comments</comments>
		<pubDate>Thu, 11 Dec 2008 15:17:55 +0000</pubDate>
		<dc:creator>Ben Lam</dc:creator>
		
		<category><![CDATA[Stock Analysis]]></category>

		<category><![CDATA[Stocks]]></category>

		<guid isPermaLink="false">http://stock-value.com/?p=145</guid>
		<description><![CDATA[NASDAQ:SSRX / Morningstar / 2007 Annual Report / Website
Company
Healthcare / Drugs
China (Serves local market)
Revenue Sources

Anemia treatment (stimulates production of red blood cells)
Platelet deficiency treatment (stimulates platelet production)
Intefen anti-cancer
Low white blood cell count (due to chemotherapy) treatment (licensed tech. from Liaoning Sunshine)

Long Term Prospects
Unknown

 Is there competition for similar products in China?
Similar products from foreign producers?

Management
Unknown
Financial [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://finance.google.com/finance?q=ssrx">NASDAQ:SSRX</a> / <a href="http://quicktake.morningstar.com/StockNet/Diagnostics.aspx?Country=USA&amp;Symbol=SSRX">Morningstar</a> / <a href="http://www.sec.gov/Archives/edgar/data/1383790/000119312508034943/d6k.htm">2007 Annual Report</a> / <a href="http://bbs.3sbio.com/en/Index.aspx">Website</a></p>
<h3>Company</h3>
<p><img class="alignright size-full wp-image-147" title="ssrx_fcf_valuation" src="http://stock-value.com/wp-content/uploads/ssrx_fcf_valuation.gif" alt="" width="298" height="699" />Healthcare / Drugs</p>
<p>China (Serves local market)</p>
<p>Revenue Sources</p>
<ul>
<li>Anemia treatment (stimulates production of red blood cells)</li>
<li>Platelet deficiency treatment (stimulates platelet production)</li>
<li>Intefen anti-cancer</li>
<li>Low white blood cell count (due to chemotherapy) treatment (licensed tech. from Liaoning Sunshine)</li>
</ul>
<h2>Long Term Prospects</h2>
<p>Unknown</p>
<ul>
<li> Is there competition for similar products in China?</li>
<li>Similar products from foreign producers?</li>
</ul>
<h2>Management</h2>
<p>Unknown</p>
<h2>Financial Strength</h2>
<p>Strong</p>
<ul>
<li>No Debt</li>
<li>112.6m in cash</li>
<li>Steady Cash Flow</li>
<li>$6 net capital/share</li>
</ul>
<h2>Capital Structure</h2>
<p>Strong</p>
<ul>
<li>No Debt</li>
</ul>
<h2>Dividends &amp; Growth</h2>
<p>Fair</p>
<ul>
<li>No dividends</li>
<li>Volatile stock price</li>
<li>High of 16 in TTM (trailing twelve months)</li>
</ul>
<h2>Bottom Line</h2>
<ul>
<li>Tons of cash</li>
<li>No costs</li>
<li>Small = Volatile</li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://stock-value.com/ssrx-s3bio-inc/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Feature - Value Investing Hurdles</title>
		<link>http://stock-value.com/feature-value-investing-hurdles/</link>
		<comments>http://stock-value.com/feature-value-investing-hurdles/#comments</comments>
		<pubDate>Thu, 11 Dec 2008 03:09:19 +0000</pubDate>
		<dc:creator>Ben Lam</dc:creator>
		
		<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://stock-value.com/?p=139</guid>
		<description><![CDATA[Humans are hard wired to be terrible investors. Learn how to not be one by recognizing common Value Investing Hurdles&#8230;
]]></description>
			<content:encoded><![CDATA[<p>Humans are hard wired to be terrible investors. Learn how to not be one by recognizing common <a href="http://stock-value.com/value-investing/value-investing-hurdles/">Value Investing Hurdles</a>&#8230;</p>
]]></content:encoded>
			<wfw:commentRss>http://stock-value.com/feature-value-investing-hurdles/feed/</wfw:commentRss>
		</item>
		<item>
		<title>ITRN Stock Value</title>
		<link>http://stock-value.com/itrn-stock-value/</link>
		<comments>http://stock-value.com/itrn-stock-value/#comments</comments>
		<pubDate>Tue, 02 Dec 2008 15:45:43 +0000</pubDate>
		<dc:creator>Ben Lam</dc:creator>
		
		<category><![CDATA[Stocks]]></category>

		<category><![CDATA[Under Analysis]]></category>

		<category><![CDATA[Seth Klarman]]></category>

		<guid isPermaLink="false">http://stock-value.com/?p=48</guid>
		<description><![CDATA[NASDAQ:ITRN 2008 Annual Report Ituran USA website
Ituran Location and Control Ltd. (Ituran) is mainly engaged in the area of location-based services, consisting of stolen vehicle recovery and tracking services. (Reuters).
Not in my area of expertise (thus long term prospects need comment from someone who knows this business).
Long Term Prospects
Two main businesses: Fleet Management (shipping trucks) [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://finance.google.com/finance?q=itrn" target="_blank">NASDAQ:ITRN</a> <a href="http://www.sec.gov/Archives/edgar/data/1337117/000117891308000495/exhibit_99-1.htm" target="_blank">2008 Annual Report</a> <a href="http://www.ituranusa.com/" target="_blank">Ituran USA website</a></p>
<p>Ituran Location and Control Ltd. (Ituran) is mainly engaged in the area of location-based services, consisting of stolen vehicle recovery and tracking services. (Reuters).</p>
<p><strong>Not in my area of expertise</strong> (thus long term prospects need comment from someone who knows this business).</p>
<h3>Long Term Prospects</h3>
<p>Two main businesses: Fleet Management (shipping trucks) &amp; stolen vehicle recovery tracking (personal &amp; commercial).</p>
<p>The Good</p>
<ul>
<li>Subscriber base is growing (up 12% from 2006)</li>
<li>Net Profit for 4Q2007 was $6.2m vs. $5.1m from 4Q2006 (with Telematics 35.8m sale income removed).</li>
<li>Sold Telematics business ($35.8m net income) &amp; shared profit thru dividend of $1.34/share</li>
</ul>
<p>The Bad</p>
<ul>
<li>Increases in revenues came partially from purchases of ERM &amp; MAPA businesses.</li>
</ul>
<p>Fleet Management is a new technology that is improving efficiency of delivery &amp; quality of service to end customers.  Imagine UPS/Fedex being able to track its fleet of delivery trucks to determine when a delivery will be made. Basically a tool for supply chain management &amp; logistics.</p>
<p>Personal stolen vehicle recovery services: not a huge market.  The average car owner has insurance which covers loss. Reduction in premiums for insurance likely don&#8217;t offset the ongoing costs of this service. Thus a small market for a specialized service. Discretionary spending product.  People need to eat.  People don&#8217;t need to track their car by satellite GPS in order to live.</p>
<p>Is ITRN a leader in its industry?</p>
<p>Does it have competition? LoJack (NASDAQ:LOJN)</p>
<p>How does it grow?</p>
<h3>Management Performance</h3>
<p>Positive cash flow for ITRN since 2004.</p>
<p>Pays a dividend.</p>
<p>&#8230; to be continued.</p>
]]></content:encoded>
			<wfw:commentRss>http://stock-value.com/itrn-stock-value/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Welcome to Stock-Value.com</title>
		<link>http://stock-value.com/stock-value-welcome/</link>
		<comments>http://stock-value.com/stock-value-welcome/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 22:02:07 +0000</pubDate>
		<dc:creator>Ben Lam</dc:creator>
		
		<category><![CDATA[General]]></category>

		<guid isPermaLink="false">http://stock-value.com/?p=1</guid>
		<description><![CDATA[Find out what Stock-Value.com is all about at our Welcome Page.
]]></description>
			<content:encoded><![CDATA[<p>Find out what Stock-Value.com is all about at our <a href="http://stock-value.com/value-investing/welcome/">Welcome Page</a>.</p>
]]></content:encoded>
			<wfw:commentRss>http://stock-value.com/stock-value-welcome/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>
